Many studies have proved that the high expression of PKM2 is closely associated with the survival of breast cancer patients, but the results are uncertain.[13–18] In order to explore the expression and clinical prognostic significance of PKM2 in breast cancer, we conducted a meta-analysis. This evidence concerns the gene PKM and breast carcinoma.